Amgen (AMGN) Tax Provisions (2009 - 2026)

Amgen's Tax Provisions history runs 18 years deep, the most recent figure standing at $265.0 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 9.05% year-over-year to $265.0 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 79.5% YoY), while the FY2025 annual figure was $1.3 billion, up 143.74% from the prior year.
• Tax Provisions for Q1 2026 stood at $265.0 million, up from $181.0 million in the prior quarter.
• The five-year high for Tax Provisions was $705.0 million in Q3 2025, with the low at $45.0 million in Q1 2024.
• The 5-year median for Tax Provisions is $214.0 million (2022), against an average of $234.2 million.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions slumped 92.51% in 2024, then soared 440.0% in 2025.
• Amgen's Tax Provisions stood at $132.0 million in 2022, then tumbled by 35.61% to $85.0 million in 2023, then surged by 82.35% to $155.0 million in 2024, then rose by 16.77% to $181.0 million in 2025, then jumped by 46.41% to $265.0 million in 2026.
• Business Quant data shows AMGN's Tax Provisions at $265.0 million in Q1 2026, $181.0 million in Q4 2025, and $705.0 million in Q3 2025.